HOME ·

Insilico

INSILICO (03696.HK): considering participation in RMB 1.01 billion investment fund focusing on biopharma
Tags：
Insilico03696.HKInvestment
2026-08-18
InSilico Medicine (03696.HK): NLRP3 Inhibitor ISM8969/HT-001 Co-Developed with Hengtai Bio Receives NMPA IND Approval for Parkinson's Disease
Tags：
Insilico03696.HK
2026-08-03
Empowered by HKIC's Patient Capital, Insilico Medicine (3696.HK) Enters $600 Million Global Strategic Partnership with Takeda
Tags：
Insilico03696.HKHKIC
2026-07-20
InSilico Medicine (03696.HK) and Bora Pharmaceuticals Announce Strategic Alliance with Potential Value Exceeding US$2.5 Billion
Tags：
Insilico03696.HK
2026-07-15
INSILICO (03696.HK): Enters CNS Drug R&D Collaboration with Cosmo Pharmaceutical, Potential Milestone Payments Up to Approximately RMB1.2 Billion
Tags：
Insilico03696.HKCMS00867.HKDrug Collaboration
2026-07-13
InSilico Medicine (03696.HK): Expects to Turn Profit in H1, Net Profit of US$33.5M to US$39.5M
Tags：
Insilico03696.HK
2026-07-09
INSILICO(03696.HK): Phase III Clinical Trial of Rentosertib for Idiopathic Pulmonary Fibrosis Officially Launched
Tags：
Insilico03696.HKClinical Trial
2026-07-08
INSILICO(03696.HK) Enters AI-Powered R&D Collaboration with SK Biopharmaceuticals, Total Potential Deal Value Exceeds USD2.5 Billion
Tags：
Insilico03696.HKResearch and Development Collaboration
2026-06-22
INSILICO(03696.HK) closed 10.1% higher
Tags：
Insilico03696.HK
2026-04-22
INSILICO(03696.HK) closed 14.06% higher, The full-day turnover stood at HKD 618.6 million
Tags：
Insilico03696.HK
2026-04-20
InSilico Medicine (03696.HK) Inks AI Drug Discovery Deal Exceeding HK$931 Million Including Sales Milestones
Tags：
Insilico03696.HKAI
2026-01-27
InSilico (03696.HK): Partnering with Servier on an $888 Million AI-Driven Anti-Tumor Innovative Drug Initiative
Tags：
Insilico03696.HKInnovative Drugs
2026-01-05
Insilico Medicine Launches Hong Kong's Largest Biopharma IPO of the Year with HKIC as Strategic Investor
Tags：
InsilicoHKICIPObiopharmaceutical
2025-12-31